Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Revefenacin | Yupelri | 4.8 Undesirable effects | Dry mouth | Apr,2023 |
| Esomeprazole | Nexium | 4.8 Undesirable effects | Impotence | Mar,2023 |
| Methotrexate | Mizotra | 4.6 Fertility, pregnancy and lactation | Contraception in males and females | Mar,2023 |
| Pemetrexed | Pemitax | 4.6 Fertility, pregnancy and lactation | Contraception in males and females | Mar,2023 |
| Paclitaxel | Anzatax | 4.6 Fertility, pregnancy and lactation | Remove pregnancy category D | Mar,2023 |
| Busulfan | Myleran | 4.6 Fertility, pregnancy and lactation | Busulfan is contraindicated during pregnancy, use effective contraception during and up to 6 months after treatment in male and female | Mar,2023 |